Dean J Mitchell insider trades
Open-market stock purchases and sales by Dean J Mitchell, Unknown at Theravance Biopharma, Inc, from SEC Form 4 filings since Apr 1, 2010.
Track record: 100% of 1 scored buy are up 5% or more since purchase, averaging +154%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Sep 23, 2026 | TBPH Theravance Biopharma, Inc | Sold (not open market) | — |
| Sep 23, 2026 | TBPH Theravance Biopharma, Inc | Sold (not open market) | — |
| Sep 23, 2026 | TBPH Theravance Biopharma, Inc | Sold (not open market) | $122K |
| Sep 23, 2026 | TBPH Theravance Biopharma, Inc | Sold (not open market) | $284K |
| Sep 23, 2026 | TBPH Theravance Biopharma, Inc | Sold (not open market) | $241K |
| Sep 23, 2026 | TBPH Theravance Biopharma, Inc | Sold (not open market) | $224K |
| Sep 23, 2026 | TBPH Theravance Biopharma, Inc | Sold (not open market) | $228K |
| Sep 23, 2026 | TBPH Theravance Biopharma, Inc | Sold (not open market) | $223K |
| Jun 12, 2026 | TBPH Theravance Biopharma, Inc | Bought (not open market) | — |
| Jun 12, 2026 | TBPH Theravance Biopharma, Inc | Bought (not open market) | — |
| Jun 10, 2026 | PRAX Praxis Precision Medicines, Inc | Bought (not open market) | — |
| Jun 10, 2026 | PRAX Praxis Precision Medicines, Inc | Bought (not open market) | — |
Companies traded
- TBPH Theravance Biopharma, Inc: other filings, last Sep 23, 2026
- PRAX Praxis Precision Medicines, Inc: 2 buys, last Jun 10, 2026
- KNTE Kinnate Biopharma Inc: other filings, last Apr 3, 2024
- PGEN Precigen, Inc: 1 buy, last Mar 14, 2024
- IMGN ImmunoGen, Inc: 1 buy, last Feb 12, 2024
- XON Intrexon Corp: 1 buy, last Mar 23, 2018
- ISTA Ista Pharmaceuticals Inc: other filings, last Jun 6, 2012
- TLCR Talecris Biotherapeutics Holdings Corp: other filings, last Jun 1, 2011